Post-Conference Perspectives: Updates in Colorectal Cancer: Highlights from ASCO GI 2023 and Beyond - Episode 1

An Introduction to Biomarker Testing in Metastatic Colorectal Cancer

Tanios S. Bekaii-Saab, MD, FACP introduces the metastatic colorectal cancer (mCRC) treatment landscape and the emphasizes importance of biomarker testing in patients with mCRC.

Now Viewing
EP. 1: An Introduction to Biomarker Testing in Metastatic Colorectal Cancer
EP. 2: Clinical Trial Review: MOUNTAINEER
EP. 3: MOUNTAINEER-03 Clinical Trial Study Design and Implications
EP. 4: Emerging Treatment Options for Patients with HER2+ Metastatic Colorectal Cancer
EP. 5: The Future of the Metastatic Colorectal Cancer Treatment Landscape